Biden's Cancer Worsens: Hunter Reveals Bone Metastasis

Former President Joe Biden is grappling with a worsening prostate cancer diagnosis, according to recent revelations by his son, Hunter Biden. The cancer has reportedly metastasized into his bones, leading to increased pain and limitations.

This development marks a serious turn for the former president, who was first diagnosed with aggressive prostate cancer in May 2025. Initial reports indicated bone involvement and a high Gleason score of 9, classifying it as a highly aggressive type.

The disease, initially hormone-sensitive, has progressed, shifting treatment focus from cure to symptom management. Metastatic prostate cancer, especially when it spreads to the bones, commonly becomes a chronic condition requiring ongoing care.

Prostate cancer, often slow-growing, can become aggressive and spread. The Gleason score is crucial for assessing its potential to grow and spread rapidly. Biden's score of 9 places his cancer at the extreme end of the spectrum.

Symptoms of prostate cancer can be vague, often including urinary issues. Biden's diagnosis followed increased urinary problems. Metastasis to bone, a common site for prostate cancer spread, can cause persistent pain and increase fracture risk.

Risk factors for prostate cancer include age, family history, and certain genetic mutations. While lifestyle factors can play a role, many causes are beyond individual control. Treatment for metastatic disease aims to slow progression and manage symptoms.

Survival rates vary significantly based on the stage at diagnosis. Localized or regional prostate cancer has high survival rates, but rates decrease substantially for metastatic disease. However, advancements in treatment offer hope for extended quality of life.